Erythropoietin in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Randomized, Double-Blind Trial

Ott, Ilka, Schulz, Stefanie, Mehilli, Julinda, Fichtner, Stefanie, Hadamitzky, Martin, Hoppe, Katharina, Ibrahim, Tareq, Martinoff, Steffan +7 more·2010·Circulation: Cardiovascular Interventions
DOI 10.1161/circinterventions.109.904425

Cited by (129)

Items 101–129 of 129

  1. Investigational new drugs for the treatment of acute coronary syndrome
    Cormac Thomas O'Connor, Thomas John Kiernan, Bryan P. Yan · 2015 · Expert Opinion on Investigational Drugs
  2. Optimizing the host substrate environment for cardiac angiogenesis, arteriogenesis, and myogenesis
    Kay Maeda, Emilio Isaac Alarcon, Erik J. Suuronen, Marc Ruel · 2017 · Expert Opinion on Biological Therapy
  3. Protective or Inhibitory Effect of Pharmacological Therapy on Cardiac Ischemic Preconditioning: A Literature Review
    Leonardo Jorge Cordeiro de Paula, Augusto Hiroshi Uchida, Paulo Cury Rezende, Paulo Rogério Soares, Thiago Luis Scudeler · 2022 · Current Vascular Pharmacology
  4. Association of admission blood glucose and in- hospital outcome after Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction
    Md Abdullah Al Mamun, Mahboob Ali, M G Azam, Shaila Nabi, Mir Jamal Uddin, Sabina Hashem, Sharadindu Shekhar Roy, Pijous Biswas, Mozammel Haque, J T Imam · 2024 · Cardiovascular Journal
  5. Emerging Concepts in Myocardial Pharmacoregeneration
    Laura Cecilia Zelarayan, Maria-Patapia Zafeiriou, Wolfram‐Hubertus Zimmermann · 2013 · Springer eBooks
  6. Novel Treatment Strategies
    Derek John Hausenloy, Derek M. Yellon · 2012 · Springer eBooks
  7. Anemia in Acute Coronary Syndrome: An Overview
    Chhabi Satpathy, Nirmal Kumar Mohanty · 2021 · Indian Journal of Cardiovascular Disease in Women
  8. Erythropoietin, progenitor cells and restenosis. A critique of Stein et al.
    Tetsuo Minamino, Ken Toba, Shuichiro Higo, Daisaku Nakatani, Takuya Ozawa · 2012 · Thrombosis and Haemostasis
  9. Proteins targeting ischaemic-reperfusion injury and repair after myocardial infarction: a systematic literature review
    Asparuh Gardev, Derek John Hausenloy, Anton Pekcec · 2026 · Cardiovascular Research
  10. A novel synthetic derivative of human erythropoietin designed to bind to glycosaminoglycans
    Masato Moriyama, Ken Toba, Haruo Hanawa, Kiminori Kato, Takao Yanagawa, Tsugumi Takayama, Takuya Ozawa, Hironori Kobayashi, Masato Higuchi, Hideki Saito et al. · 2012 · Drug Delivery
  11. ERYTHROPOIETIN IN MYOCARDIAL INFARCTION: EXPERIMENTAL EVIDENCE AND CLINICAL STUDIES
    Andreas Stein, Ilka Ott · 2011 · European Journal of Cardiovascular Medicine
  12. Percutaneous Coronary Intervention in Acute ST Segment Elevation Myocardial Infarction
    Albert Schömig, Gjin Ndrepepa, Robert A. Byrne, Adnan Kastrati · 2012 · Elsevier eBooks
  13. Evaluation of the Prospective Observation of Erythropoietin-administration for the Treatment of Acute Myocardial Infarction (EPO/AMI-1) Study.
    Ken Toba, Kiminori Kato, Takuya Ozawa, Yoshifusa Aizawa · 2011 · Nihon Naika Gakkai Zasshi
  14. Erythropoietin and Its Derivatives
    Tanya Bogoslovsky, Joshua D. Bernstock, Kimbra Kenney, Carol B. Moore, Ramon R. Diaz-Arrastia · 2016 · Elsevier eBooks
  15. Development of nanomedicines for inflammation disorders : evaluation of pharmacological efficacy on preclinical models
    Flavio Dormont · 2019 · theses.fr (ABES)
  16. Reducing Infarct Size With EPO in Patients With ST-Segment Elevation Myocardial Infarction
    Hicham Skali, Scott David Solomon · 2011 · American Journal of Kidney Diseases
  17. Still Searching for a New Therapeutic Strategy for Acute Myocardial Infarction
    Yoshihiko Saito · 2010 · Circulation Journal
  18. Effects of Erythropoietin on Blood Vessels and the Heart
    2013 · BENTHAM SCIENCE PUBLISHERS eBooks
  19. Reducing Infarct Size With EPO in Patients With ST-Segment Elevation Myocardial Infarction
    Rao Sv, Chiara Melloni · 2011
  20. Peroxynitrite - matrix metalloproteinase and erythropoietin receptor signaling pathways in ischemic heart disease
    Krisztina Kiss · 2017
  21. The use of pharmacological conditioning strategies to improve donor heart preservation in cardiac transplantation
    G. Kumarasinghe · 2022 · UNSWorks (University of New South Wales, Sydney, Australia)
  22. Erythropoietin Therapy in Critically Ill and Acute Kidney Injury Patients
    Zoltan Huba Endre, Steve Elliott · 2019 · Elsevier eBooks
  23. The Year in Interventional Cardiology
    Simon R. Dixon, Cindy Lee Grines · 2011 · Journal of the American College of Cardiology
  24. Myocardial Pharmacoregeneration
    Laura Cecilia Zelarayan, Maria-Patapia Zafeiriou, Wolfram‐Hubertus Zimmermann · 2016 · Springer eBooks
  25. Circulation: Cardiovascular Interventions Editors’ Picks
    The Editors · 2012 · Circulation Cardiovascular Interventions
  26. Most Important Papers in ST-Elevation Myocardial Infarction
    The Editors · 2011 · Circulation Cardiovascular Interventions
  27. Circulation Editors' Picks
    The Editors · 2012 · Circulation
  28. Étude de l'effet de nouveaux ligands de la cyclophiline D sur le pore de transition de perméabilité mitochondrial et de leur effet protecteur
    Mathieu Panel · 2018 · theses.fr (ABES)
  29. Allogeneic cardiac stem/progenitor cells and innate immune and humoral responses
    Thi Nhu Quynh Dam Noémie · 2018 · theses.fr (ABES)